Home
Live Updates
Sage Touts Strong Launch for Postpartum Depression Drug Zurzuvae : comparemela.com
Sage Touts Strong Launch for Postpartum Depression Drug Zurzuvae
Despite missing out on an FDA approval for major depressive disorder, Zurzuvae appears to be a strong asset for Sage Therapeutics, with high growth potential in 2024.
Related Keywords
Massachusetts ,
United States ,
Barry Greene ,
,
Sage Therapeutic ,
Resume ,
Careers ,
Age Touts Strong Launch For Postpartum Depression Drug Zurzuvae ,
Iospace ,
Advice ,
comparemela.com © 2020. All Rights Reserved.